feed,title,long_url,short_url
Benzinga,"This Hepatitis Stock Has 'Multiple Paths To Value Creation,' Expects To Double, Bullish Analyst Predicts",https://benzinga.com/general/biotech/22/09/28870025/analyst-says-this-hepatitis-stock-has-multiple-paths-to-value-creation,https://bit.ly/3eLR5SW
